Funding for this research was provided by:
National Cancer Institute (R35 CA209859)
Received: 11 January 2021
Accepted: 3 August 2021
First Online: 16 August 2021
: All human subjects research conducted under this retrospective study was reviewed and approved by the institutional review board at the University of Southern California (HS-16-00840) and following written informed consent from all patients. These experimental methods comply with Helsinki Declaration.
: Written informed consent for publication was obtained from the patients/participants at enrollment.
: D.J. Weisenberger is a paid consultant of Zymo Research Corporation. The remaining authors declare that they have no competing interests.